Transaction in Own Shares

Summary by AI BETAClose X

On September 1, 2025, GSK plc, acting through its broker Merrill Lynch International, purchased 227,465 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought on the London Stock Exchange at prices ranging from 1,442.00p to 1,468.50p per share, with a volume-weighted average price of 1,451.50p. These shares will be held as treasury shares as part of an existing buyback program that began on June 4, 2025, since which date the company has purchased 26,501,553 ordinary shares. Following this transaction, GSK will hold 244,635,936 ordinary shares in treasury, with 4,070,760,160 ordinary shares in issue excluding treasury shares; the treasury shares represent 6.01 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today